Intra-articular injection of secretome, derived from umbilical cord mesenchymal stem cell, enhances the regeneration process of cartilage in early-stage osteo-arthritis: an animal study
DOI:
https://doi.org/10.2340/17453674.2023.12359Keywords:
Hyaluronic acid, mesenchymal stem cells, osteoarthritis, secretomeAbstract
Background and purpose: Mesenchymal stem cells (MSCs), both endogenous and exogenous, enhance chondrocyte proliferation by stimulating collagen type II. Secretome, an MSC derivate, has shown to also provide this mechanism through a paracrine effect. We aimed to evaluate the use of secretome and MSC in the management of early osteoarthritis (OA).
Animals and methods: 19 (1 control) male sheep (Ovies aries), which were operated on with total lateral meniscectomy to induce knee OA, were divided into 3 groups: the secretome group, hyaluronic acid group, and MSC group. Each group was injected with the respective substances and was evaluated macroscopically and microscopically. The Osteoarthritis Research Society International (OARSI) score was calculated for all subjects and a descriptive and comparative statistical analysis was undertaken.
Results: The macroscopic analysis of the treated groups revealed better OARSI score in the secretome group compared with the other 2 groups. The secretome group showed a significantly better microscopic score compared with the hyaluronic acid group (mean difference [MD] 6.0, 95% confidence interval [CI] 0.15–12), but no significant difference compared with the MSC group (MD 1.0, CI –4.8 to 6.8).
Conclusion: Intra-articular injection of secretome is effective in managing early-stage osteoarthritis in the animal model compared with hyaluronic acid and has similar efficacy to MSC injection.
Downloads
References
Bowman S, Awad M E, Hamrick M W, Hunter M, Fulzele S. Recent advances in hyaluronic acid based therapy for osteoarthritis. Clin Transl Med 2018; 7(1): 6. doi: 10.1186/s40169-017-0180-3. DOI: https://doi.org/10.1186/s40169-017-0180-3
Johansen M, Bahrt H, Altman R, Bartels E, Juhl C, Bliddal H, et al. Addressing controversies around intra-articular injections with hyaluronic acid in the treatment of osteoarthritis: meta-regression analyses of randomized trials. Osteoarthritis Cartilage 2015; 23: A47. doi: 10.1016/j.joca.2015.02.103. DOI: https://doi.org/10.1016/j.joca.2015.02.103
Lubis A M, Lubis V K. Adult bone marrow stem cells in cartilage therapy. Acta Med Indones 2012; 44(1): 62-8. PMID: 22451188.
Newman B, Wallis G A. Is osteoarthritis a genetic disease? Clin Invest Med 2002; 25(4): 139-49. PMID: 12220042.
Rani S, Ryan A E, Griffin M D, Ritter T. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol Ther 2015; 23(5): 812-23. doi: 10.1038/mt.2015.44/ DOI: https://doi.org/10.1038/mt.2015.44
Jeong S Y, Kim D H, Ha J, Jin H J, Kwon S-J, Chang J W, et al. Thrombospondin-2 secreted by human umbilical cord blood-derived mesenchymal stem cells promotes chondrogenic differentiation. Stem Cells 2013; 31(10): 2136-48. doi: 10.1002/stem.1471/ DOI: https://doi.org/10.1002/stem.1471
Festing M F W. Randomized block experimental designs can increase the power and reproducibility of laboratory animal experiments. ILAR J 2014; 55(3): 472-6. doi: 10.1093/ilar/ilu045/ DOI: https://doi.org/10.1093/ilar/ilu045
Liu H, Ding J, Wang J, Wang Y, Yang M, Zhang Y, et al. Remission of collagen-induced arthritis through combination therapy of microfracture and transplantation of thermogel-encapsulated bone marrow mesenchymal stem cells. Shi X-M, editor. PLoS One 2015; 10(3): e0120596. doi: 10.1371/journal.pone.0120596. DOI: https://doi.org/10.1371/journal.pone.0120596
Kraus V B, Huebner J L, DeGroot J, Bendele A. The OARSI histopathology initiative: recommendations for histological assessments of osteoarthritis in the guinea pig. Osteoarthritis Cartilage 2010; 18: S35-52. doi: 10.1016/j.joca.2010.04.015. DOI: https://doi.org/10.1016/j.joca.2010.04.015
Waldstein W, Perino G, Gilbert S L, Maher S A, Windhager R, Boettner F. OARSI osteoarthritis cartilage histopathology assessment system: a biomechanical evaluation in the human knee. J Orthop Res 2016; 34(1): 135-40. doi: 10.1002/jor.23010. DOI: https://doi.org/10.1002/jor.23010
Colombini A, Perucca Orfei C, Kouroupis D, Ragni E, De Luca P, Viganò M, et al. Mesenchymal stem cells in the treatment of articular cartilage degeneration: new biological insights for an old-timer cell. Cytotherapy 2019; 21(12): 1179-97. doi: 10.1016/j.jcyt.2019.10.004. DOI: https://doi.org/10.1016/j.jcyt.2019.10.004
Mancuso P, Raman S, Glynn A, Barry F, Murphy J M. Mesenchymal stem cell therapy for osteoarthritis: the critical role of the cell secretome. Front Bioeng Biotechnol 2019; 7: 9. doi: 10.3389/fbioe.2019.00009. DOI: https://doi.org/10.3389/fbioe.2019.00009
Schneider M C, Barnes C A, Bryant S J. Characterization of the chondrocyte secretome in photoclickable poly(ethylene glycol) hydrogels. Biotechnol Bioeng 2017; 114(9): 2096-108. doi: 10.1002/bit.26320. DOI: https://doi.org/10.1002/bit.26320
Kim H J, Park J-S. Usage of human mesenchymal stem cells in cell-based therapy: advantages and disadvantages. Dev Reprod 2017; 21(1): 1-10. doi: 10.12717/DR.2017.21.1.001. DOI: https://doi.org/10.12717/DR.2017.21.1.001
Khatab S, van Osch G, Kops N, Bastiaansen-Jenniskens Y, Bos P, Verhaar J, et al. Mesenchymal stem cell secretome reduces pain and prevents cartilage damage in a murine osteoarthritis model. Eur Cells Mater 2018; 36: 218-30. doi: 10.22203/eCM.v036a16. DOI: https://doi.org/10.22203/eCM.v036a16
Iannone M, Ventre M, Formisano L, Casalino L, Patriarca E J, Netti P A. Nanoengineered surfaces for focal adhesion guidance trigger mesenchymal stem cell self-organization and tenogenesis. Nano Lett 2015; 15(3): 1517-25. doi: 10.1021/nl503737k. DOI: https://doi.org/10.1021/nl503737k
Loeser R F. Integrins and chondrocyte-matrix interactions in articular cartilage. Matrix Biol 2014; 39: 11-16. doi: 10.1016/j.matbio.2014.08.007. DOI: https://doi.org/10.1016/j.matbio.2014.08.007
Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31(10): 890-6. doi: 10.1016/s0301-472x(03)00110-3. DOI: https://doi.org/10.1016/S0301-472X(03)00110-3
Giannasi C, Niada S, Della Morte E, Casati S, Orioli M, Gualerzi A, et al. Towards secretome standardization: identifying key ingredients of MSC-derived therapeutic cocktail. Paspaliaris V, editor. Stem Cells Int 2021; 2021: 1-13. doi: 10.1155/2021/3086122. DOI: https://doi.org/10.1155/2021/3086122
Bail H, Klein P, Kolbeck S, Krummrey G, Weiler A, Schmidmaier G, et al. Systemic application of growth hormone enhances the early healing phase of osteochondral defects: a preliminary study in micropigs. Bone 2003; 32(5): 457-67. doi: 10.1016/s875-63282(03)00051-6. DOI: https://doi.org/10.1016/S8756-3282(03)00051-6
Altman R, Manjoo A, Fierlinger A, Niazi F, Nicholls M. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord 2015; 16(1): 321. doi: 10.1186/s12891-015-0775-z. DOI: https://doi.org/10.1186/s12891-015-0775-z
Maheshwer B, Polce E M, Paul K, Williams B T, Wolfson T S, Yanke A, et al. Regenerative potential of mesenchymal stem cells for the treatment of knee osteoarthritis and chondral defects: a systematic review and meta-analysis. Arthroscopy 2021; 37(1): 362-78. doi: 10.1016/j.arthro.2020.05.037. DOI: https://doi.org/10.1016/j.arthro.2020.05.037
Additional Files
Published
How to Cite
License
Copyright (c) 2023 Andri Maruli Tua Lubis, Petrus Aprianto, Jeanne Adiwinata Pawitan, Bambang Pontjo Priosoeryanto, Tri Isyani Tungga Dewi, Achmad Fauzi Kamal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
